2412 Stock Overview
Hunan Hansen Pharmaceutical Co., Ltd. produces and sells traditional Chinese preparations in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Hunan Hansen Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.23 |
| 52 Week High | CN¥7.38 |
| 52 Week Low | CN¥4.08 |
| Beta | 0.33 |
| 1 Month Change | -1.88% |
| 3 Month Change | -13.55% |
| 1 Year Change | -21.23% |
| 3 Year Change | -12.40% |
| 5 Year Change | -52.83% |
| Change since IPO | -17.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2412 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 3.6% | 4.9% | 2.1% |
| 1Y | -21.2% | -13.4% | -14.2% |
Return vs Industry: 002412 underperformed the CN Pharmaceuticals industry which returned -14.4% over the past year.
Return vs Market: 002412 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 2412 volatility | |
|---|---|
| 2412 Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002412 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002412's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,533 | Zhengqing Liu | www.hansenzy.com |
Hunan Hansen Pharmaceutical Co., Ltd. produces and sells traditional Chinese preparations in China and internationally. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd.
Hunan Hansen Pharmaceutical Co., Ltd. Fundamentals Summary
| 2412 fundamental statistics | |
|---|---|
| Market cap | CN¥2.63b |
| Earnings (TTM) | CN¥147.28m |
| Revenue (TTM) | CN¥919.05m |
17.9x
P/E Ratio2.9x
P/S RatioIs 2412 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2412 income statement (TTM) | |
|---|---|
| Revenue | CN¥919.05m |
| Cost of Revenue | CN¥263.83m |
| Gross Profit | CN¥655.22m |
| Other Expenses | CN¥507.94m |
| Earnings | CN¥147.28m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | 0.29 |
| Gross Margin | 71.29% |
| Net Profit Margin | 16.03% |
| Debt/Equity Ratio | 4.8% |
How did 2412 perform over the long term?
See historical performance and comparison